Hetero Drugs Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is INDOMETHACIN, with a corresponding US DMF Number 36364.
Remarkably, this DMF maintains an Active status since its submission on October 23, 2021, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 22, 2021, and payment made on October 21, 2021, indicating their dedication to facilitating drug approvals, Categorized as Type II